Appendix Procedures without CC/MCC DRG Reimbursement

DRG 399 encompasses appendix procedures without Major Complication or Comorbidity or Complication or Comorbidity, typically including straightforward appendectomies. Classification to this Diagnosis-Related Group influences inpatient reimbursement under Medicare by reflecting lower expected resource use compared with higher-severity appendix groups.

DRG 399 Overview

DRG 399 covers inpatient hospital admissions for patients undergoing appendix procedures without a Major Complication or Comorbidity and without a Complication or Comorbidity. This Diagnosis-Related Group applies when appendix operations are performed for conditions such as acute appendicitis or appendiceal mass and no higher-severity comorbid diagnoses are present. It matters for Medicare payment because assignment to this Diagnosis-Related Group affects base payment rates, resource intensity calculations, and hospital reimbursement under the Medicare inpatient prospective payment system. Accurate coding and documentation determine whether an admission is classified to this Diagnosis-Related Group rather than a higher-severity appendectomy-related group.

Acute intervention studies evaluating minimally invasive versus open appendectomy techniques in patients presenting with uncomplicated appendicitis; these trials focus on immediate perioperative outcomes such as operative time, complication rates, pain scores, and length of stay among primarily adult and adolescent populations undergoing index appendectomy. Research of this type is relevant to providers because it informs best-surgical-practice choices and perioperative pathways, and it is relevant to payers because differences in resource utilization and short-term hospitalization costs directly affect reimbursement and DRG-related cost containment.
Comparative effectiveness trials assessing antibiotic-first (nonoperative) management versus surgical appendectomy in patients with early, uncomplicated appendicitis, including subgroup analyses by age, comorbidity burden, and imaging findings; these studies examine rates of treatment success, need for subsequent appendectomy, readmissions, and healthcare utilization over 1 year. This research addresses a clinically meaningful decision point for providers and health systems about avoiding surgery in selected patients and is important to payers for predicting long-term costs and readmission risk associated with nonoperative pathways under the DRG.
Post-discharge outcomes and health services research evaluating recovery trajectories, return-to-work, and unplanned healthcare encounters after appendectomy among diverse patient groups (older adults, patients with diabetes or obesity, and pediatric patients); these observational cohort studies track 30‑ and 90‑day outcomes such as wound infection, emergency visits, and resource use across different discharge dispositions and perioperative care bundles. Findings help providers refine discharge criteria and follow-up protocols, and help payers identify drivers of post-discharge utilization that influence total cost of care within the DRG and opportunities for targeted interventions to reduce complications and readmissions.

Acute intervention studies evaluating minimally invasive versus open appendectomy techniques in patients presenting with uncomplicated appendicitis; these trials focus on immediate perioperative outcomes such as operative time, complication rates, pain scores, and length of stay among primarily adult and adolescent populations undergoing index appendectomy. Research of this type is relevant to providers because it informs best-surgical-practice choices and perioperative pathways, and it is relevant to payers because differences in resource utilization and short-term hospitalization costs directly affect reimbursement and DRG-related cost containment.
Comparative effectiveness trials assessing antibiotic-first (nonoperative) management versus surgical appendectomy in patients with early, uncomplicated appendicitis, including subgroup analyses by age, comorbidity burden, and imaging findings; these studies examine rates of treatment success, need for subsequent appendectomy, readmissions, and healthcare utilization over 1 year. This research addresses a clinically meaningful decision point for providers and health systems about avoiding surgery in selected patients and is important to payers for predicting long-term costs and readmission risk associated with nonoperative pathways under the DRG.
Post-discharge outcomes and health services research evaluating recovery trajectories, return-to-work, and unplanned healthcare encounters after appendectomy among diverse patient groups (older adults, patients with diabetes or obesity, and pediatric patients); these observational cohort studies track 30‑ and 90‑day outcomes such as wound infection, emergency visits, and resource use across different discharge dispositions and perioperative care bundles. Findings help providers refine discharge criteria and follow-up protocols, and help payers identify drivers of post-discharge utilization that influence total cost of care within the DRG and opportunities for targeted interventions to reduce complications and readmissions.

OpenPayer

Summary & Overview

Appendix Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 399 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes